HER2 positivity is defined in gastric cancer as the presence of protein expression with immunohistochemistry score [IHC] of 3 + or IHC 2 + and concomitant gene amplification on in situ hybridization [ISH], HER2/CEP17 ratio ≥ 2.0. Here, ERBB2 is linked to gastric cancer.